ROCK2 and graft versus host disease: Belumosudil (BEL) is a specific inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), which has shown great potential as a therapy for inflammatory and autoimmune illnesses, including graft-versus-host disease (GVHD).